DAL
70
-6
PYPL
50
-6
JWN
59
2
SLG
55
-4
TXT
53
-2
SE
65
2
IVZ
52
-3
HRL
45
-2
SO
51
-4
ESS
59
-3
FOX
42
-8
EOG
49
2
MTB
61
-3
EIX
69
-3
NTRS
55
-2
DE
62
-3
LYB
39
-2
MS
62
-7
JCI
47
-7
NWS
90
26
DAL
70
-6
PYPL
50
-6
JWN
59
2
SLG
55
-4
TXT
53
-2
SE
65
2
IVZ
52
-3
HRL
45
-2
SO
51
-4
ESS
59
-3
FOX
42
-8
EOG
49
2
MTB
61
-3
EIX
69
-3
NTRS
55
-2
DE
62
-3
LYB
39
-2
MS
62
-7
JCI
47
-7
NWS
90
26
Financhill
Back

Expedia Group Vs. NovoCure Industry Stock Comparison

Buy
88

EXPE
Expedia Group

Last Price:
186.00
Seasonality Move:
0.68%
Buy
77

NVCR
NovoCure

Last Price:
30.06
Seasonality Move:
2.04%
Buy
88
Expedia Group (EXPE) is a Buy

Is Expedia Group a Buy, Sell or Hold?

  • The current Expedia Group [EXPE] share price is $183.69. The Score for EXPE is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
  • EXPE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EXPE Stock Price Chart

What is Expedia Group's stock price today?

  • The Expedia Group share price today is $183.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

EXPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 65.05 Buy
Chaikin Money Flow: -477401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (166.72 - 186.26) Buy
Bollinger Bands (100): (128.17 - 167.95) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

EXPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 184.63 Sell
20-day SMA: 180.78 Buy
50-day SMA: 164.32 Buy
200-day SMA: 137.61 Buy
8-day EMA: 183.76 Sell
20-day EMA: 178.99 Buy
50-day EMA: 166.6 Buy
200-day EMA: 143.09 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

Expedia Group Earnings Growth & EXPE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.11 per share, and an increase next year of $2.36 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Expedia Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):